Giulia Cossu1, Emmanuel Jouanneau2, Luigi M Cavallo3, Samer K Elbabaa4, Lorenzo Giammattei1, Daniele Starnoni1, Juan Barges-Coll1, Paolo Cappabianca3, Vladimir Benes5, Mustafa K Baskaya6, Michael Bruneau7, Torstein Meling8, Karl Schaller8, Ari G Chacko9, A Samy Youssef10, Diego Mazzatenta11, Mario Ammirati12, Henry Dufour13, Edward Laws14, Moncef Berhouma2, Roy Thomas Daniel1, Mahmoud Messerer15. 1. Department of Neurosurgery, University Hospital of Lausanne, Lausanne, Switzerland. 2. Department of Neurosurgery, Hopital Neurologique Pierre Wertheimer, Lyon, France. 3. Department of Neurosurgery, University Hospital of Naples Federico II, Napoli, NA, Italy. 4. Department of Pediatric Neurosurgery, Arnold Palmer Hospital for Children, Orlando, FL, USA. 5. Department of Neurosurgery, Central Military Hospital, Prague, Czech Republic. 6. Department of Neurological Surgery, University of Wisconsin Medical School and Public Health, Madison, USA. 7. Department of Neurosurgery, Erasme Hospital, Brussels, Belgium. 8. Department of Neurosurgery, University Hospital of Geneva, Geneva, Switzerland. 9. Department of Neurological Science, Christian Medical College, Vellore, Tamilnadu, India. 10. Department of Neurosurgery and Otolaryngology, University of Colorado School of Medicine, Aurora, CO, USA. 11. IRCCS Institute of neurological sciences of Bologna, Bellaria Hospital, Bologna, Italy. 12. Center for Biotechnology Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, USA. 13. Department of Neurosurgery, Hopital de la Timone, Marseille, France. 14. Pituitary Neuroendocrine Center, Brigham and Women's Hospital, Boston, MA, USA. 15. Department of Neurosurgery, University Hospital of Lausanne, Lausanne, Switzerland. Mahmoud.messerer@chuv.ch.
Abstract
BACKGROUND AND OBJECTIVE: Craniopharyngiomas are locally aggressive neuroepithelial tumors infiltrating nearby critical neurovascular structures. The majority of published surgical series deal with childhood-onset craniopharyngiomas, while the optimal surgical management for adult-onset tumors remains unclear. The aim of this paper is to summarize the main principles defining the surgical strategy for the management of craniopharyngiomas in adult patients through an extensive systematic literature review in order to formulate a series of recommendations. MATERIAL AND METHODS: The MEDLINE database was systematically reviewed (January 1970-February 2019) to identify pertinent articles dealing with the surgical management of adult-onset craniopharyngiomas. A summary of literature evidence was proposed after discussion within the EANS skull base section. RESULTS: The EANS task force formulated 13 recommendations and 4 suggestions. Treatment of these patients should be performed in tertiary referral centers. The endonasal approach is presently recommended for midline craniopharyngiomas because of the improved GTR and superior endocrinological and visual outcomes. The rate of CSF leak has strongly diminished with the use of the multilayer reconstruction technique. Transcranial approaches are recommended for tumors presenting lateral extensions or purely intraventricular. Independent of the technique, a maximal but hypothalamic-sparing resection should be performed to limit the occurrence of postoperative hypothalamic syndromes and metabolic complications. Similar principles should also be applied for tumor recurrences. Radiotherapy or intracystic agents are alternative treatments when no further surgery is possible. A multidisciplinary long-term follow-up is necessary.
BACKGROUND AND OBJECTIVE:Craniopharyngiomas are locally aggressive neuroepithelial tumors infiltrating nearby critical neurovascular structures. The majority of published surgical series deal with childhood-onset craniopharyngiomas, while the optimal surgical management for adult-onset tumors remains unclear. The aim of this paper is to summarize the main principles defining the surgical strategy for the management of craniopharyngiomas in adult patients through an extensive systematic literature review in order to formulate a series of recommendations. MATERIAL AND METHODS: The MEDLINE database was systematically reviewed (January 1970-February 2019) to identify pertinent articles dealing with the surgical management of adult-onset craniopharyngiomas. A summary of literature evidence was proposed after discussion within the EANS skull base section. RESULTS: The EANS task force formulated 13 recommendations and 4 suggestions. Treatment of these patients should be performed in tertiary referral centers. The endonasal approach is presently recommended for midline craniopharyngiomas because of the improved GTR and superior endocrinological and visual outcomes. The rate of CSF leak has strongly diminished with the use of the multilayer reconstruction technique. Transcranial approaches are recommended for tumors presenting lateral extensions or purely intraventricular. Independent of the technique, a maximal but hypothalamic-sparing resection should be performed to limit the occurrence of postoperative hypothalamic syndromes and metabolic complications. Similar principles should also be applied for tumor recurrences. Radiotherapy or intracystic agents are alternative treatments when no further surgery is possible. A multidisciplinary long-term follow-up is necessary.
Entities:
Keywords:
Craniopharyngioma; Endoscopy; Pituitary; Skull base; Surgery
Authors: M Mazzuia Guimarães; D Dante Cardeal; M Jacobsen Teixeira; J Erasmo Dal Col Lucio; F Hada Sanders; R Kei Kuromoto; H Matushita Journal: Childs Nerv Syst Date: 2021-10-07 Impact factor: 1.475
Authors: Sergey Gorelyshev; Alexander N Savateev; Nadezhda Mazerkina; Olga Medvedeva; Alexander N Konovalov Journal: Adv Tech Stand Neurosurg Date: 2022
Authors: Antonio Martínez-Ortega; Álvaro Flores-Martinez; Eva Venegas-Moreno; Elena Dios; Diego Del Can; Eloy Rivas; Ariel Kaen; Eugenio Cárdenas Ruiz-Valdepeñas; Elena Fajardo; Florinda Roldán; Natividad González-Rivera; Rosario Oliva; José Ignacio Fernández-Peña; Alfonso Soto-Moreno; David A Cano Journal: J Clin Med Date: 2022-01-05 Impact factor: 4.241
Authors: Margaret C S Boguszewski; Adriane A Cardoso-Demartini; Cesar Luiz Boguszewski; Wassim Chemaitilly; Claire E Higham; Gudmundur Johannsson; Kevin C J Yuen Journal: Pituitary Date: 2021-07-25 Impact factor: 4.107